The Role of Imaging in Bladder Cancer Diagnosis and Staging
Bladder cancer (BC) is the most common cancer of the urinary tract in the United States. Imaging plays a significant role in the management of patients with BC, including the locoregional staging and evaluation for distant metastatic disease, which cannot be assessed at the time of cystoscopy and bi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/10/9/703 |
| _version_ | 1827706053259689984 |
|---|---|
| author | Samuel J. Galgano Kristin K. Porter Constantine Burgan Soroush Rais-Bahrami |
| author_facet | Samuel J. Galgano Kristin K. Porter Constantine Burgan Soroush Rais-Bahrami |
| author_sort | Samuel J. Galgano |
| collection | DOAJ |
| description | Bladder cancer (BC) is the most common cancer of the urinary tract in the United States. Imaging plays a significant role in the management of patients with BC, including the locoregional staging and evaluation for distant metastatic disease, which cannot be assessed at the time of cystoscopy and biopsy/resection. We aim to review the current role of cross-sectional and molecular imaging modalities for the staging and restaging of BC and the potential advantages and limitations of each imaging modality. CT is the most widely available and frequently utilized imaging modality for BC and demonstrates good performance for the detection of nodal and visceral metastatic disease. MRI offers potential value for the locoregional staging and evaluation of muscular invasion of BC, which is critically important for prognostication and treatment decision-making. FDG-PET/MRI is a novel hybrid imaging modality combining the advantages of both MRI and FDG-PET/CT in a single-setting comprehensive staging examination and may represent the future of BC imaging evaluation. |
| first_indexed | 2024-03-10T16:16:40Z |
| format | Article |
| id | doaj.art-074da056010c492e8e074b84e2c92ed0 |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-10T16:16:40Z |
| publishDate | 2020-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-074da056010c492e8e074b84e2c92ed02023-11-20T13:59:42ZengMDPI AGDiagnostics2075-44182020-09-0110970310.3390/diagnostics10090703The Role of Imaging in Bladder Cancer Diagnosis and StagingSamuel J. Galgano0Kristin K. Porter1Constantine Burgan2Soroush Rais-Bahrami3Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35249, USADepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35249, USADepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35249, USADepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35249, USABladder cancer (BC) is the most common cancer of the urinary tract in the United States. Imaging plays a significant role in the management of patients with BC, including the locoregional staging and evaluation for distant metastatic disease, which cannot be assessed at the time of cystoscopy and biopsy/resection. We aim to review the current role of cross-sectional and molecular imaging modalities for the staging and restaging of BC and the potential advantages and limitations of each imaging modality. CT is the most widely available and frequently utilized imaging modality for BC and demonstrates good performance for the detection of nodal and visceral metastatic disease. MRI offers potential value for the locoregional staging and evaluation of muscular invasion of BC, which is critically important for prognostication and treatment decision-making. FDG-PET/MRI is a novel hybrid imaging modality combining the advantages of both MRI and FDG-PET/CT in a single-setting comprehensive staging examination and may represent the future of BC imaging evaluation.https://www.mdpi.com/2075-4418/10/9/703urothelial carcinomamagnetic resonance imagingpositron emission tomographycomputed tomographycancer stagingmuscle-invasive bladder cancer |
| spellingShingle | Samuel J. Galgano Kristin K. Porter Constantine Burgan Soroush Rais-Bahrami The Role of Imaging in Bladder Cancer Diagnosis and Staging Diagnostics urothelial carcinoma magnetic resonance imaging positron emission tomography computed tomography cancer staging muscle-invasive bladder cancer |
| title | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| title_full | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| title_fullStr | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| title_full_unstemmed | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| title_short | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| title_sort | role of imaging in bladder cancer diagnosis and staging |
| topic | urothelial carcinoma magnetic resonance imaging positron emission tomography computed tomography cancer staging muscle-invasive bladder cancer |
| url | https://www.mdpi.com/2075-4418/10/9/703 |
| work_keys_str_mv | AT samueljgalgano theroleofimaginginbladdercancerdiagnosisandstaging AT kristinkporter theroleofimaginginbladdercancerdiagnosisandstaging AT constantineburgan theroleofimaginginbladdercancerdiagnosisandstaging AT soroushraisbahrami theroleofimaginginbladdercancerdiagnosisandstaging AT samueljgalgano roleofimaginginbladdercancerdiagnosisandstaging AT kristinkporter roleofimaginginbladdercancerdiagnosisandstaging AT constantineburgan roleofimaginginbladdercancerdiagnosisandstaging AT soroushraisbahrami roleofimaginginbladdercancerdiagnosisandstaging |